

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.78035464 |
| 2 | viral transcription (GO:0019083) | 5.18349237 |
| 3 | translational termination (GO:0006415) | 5.04605122 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 5.01140207 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.01024261 |
| 6 | respiratory electron transport chain (GO:0022904) | 4.95706152 |
| 7 | electron transport chain (GO:0022900) | 4.86906247 |
| 8 | DNA deamination (GO:0045006) | 4.79942558 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.75900418 |
| 10 | proteasome assembly (GO:0043248) | 4.75583431 |
| 11 | protein complex biogenesis (GO:0070271) | 4.72586663 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 4.72251637 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 4.67619375 |
| 14 | protein targeting to ER (GO:0045047) | 4.64909775 |
| 15 | ribosomal large subunit biogenesis (GO:0042273) | 4.52430501 |
| 16 | translational elongation (GO:0006414) | 4.46319581 |
| 17 | protein localization to endoplasmic reticulum (GO:0070972) | 4.43670658 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 4.42622141 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.41104944 |
| 20 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.32829714 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.32216638 |
| 22 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.24273897 |
| 23 | NADH dehydrogenase complex assembly (GO:0010257) | 4.24273897 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.24273897 |
| 25 | protein neddylation (GO:0045116) | 4.15970342 |
| 26 | translational initiation (GO:0006413) | 4.12516254 |
| 27 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.06852675 |
| 28 | viral life cycle (GO:0019058) | 3.98463483 |
| 29 | respiratory chain complex IV assembly (GO:0008535) | 3.97149958 |
| 30 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.93809559 |
| 31 | cytochrome complex assembly (GO:0017004) | 3.92479405 |
| 32 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.91302012 |
| 33 | cellular protein complex disassembly (GO:0043624) | 3.88644981 |
| 34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.87982993 |
| 35 | termination of RNA polymerase III transcription (GO:0006386) | 3.86409573 |
| 36 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.86409573 |
| 37 | translation (GO:0006412) | 3.86140577 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.77334202 |
| 39 | telomere maintenance via recombination (GO:0000722) | 3.75396307 |
| 40 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.74723756 |
| 41 | DNA strand elongation (GO:0022616) | 3.73685787 |
| 42 | formation of translation preinitiation complex (GO:0001731) | 3.69482370 |
| 43 | protein targeting to mitochondrion (GO:0006626) | 3.65230233 |
| 44 | DNA replication checkpoint (GO:0000076) | 3.61540610 |
| 45 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.58563536 |
| 46 | ATP biosynthetic process (GO:0006754) | 3.55154660 |
| 47 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.53434823 |
| 48 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.53219988 |
| 49 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.52646719 |
| 50 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.52301695 |
| 51 | GTP biosynthetic process (GO:0006183) | 3.47988674 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.46722404 |
| 53 | purine nucleobase biosynthetic process (GO:0009113) | 3.44452822 |
| 54 | DNA replication initiation (GO:0006270) | 3.43841500 |
| 55 | establishment of protein localization to mitochondrion (GO:0072655) | 3.43796825 |
| 56 | rRNA modification (GO:0000154) | 3.42644075 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.42635409 |
| 58 | negative regulation of ligase activity (GO:0051352) | 3.42635409 |
| 59 | peptidyl-histidine modification (GO:0018202) | 3.42545809 |
| 60 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.41991813 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.40843990 |
| 62 | rRNA processing (GO:0006364) | 3.40809218 |
| 63 | nucleobase biosynthetic process (GO:0046112) | 3.38335140 |
| 64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.36993063 |
| 65 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.36809096 |
| 66 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.34342155 |
| 67 | cellular component biogenesis (GO:0044085) | 3.33857662 |
| 68 | CENP-A containing nucleosome assembly (GO:0034080) | 3.33805372 |
| 69 | protein complex disassembly (GO:0043241) | 3.32808705 |
| 70 | mitotic recombination (GO:0006312) | 3.32741130 |
| 71 | spliceosomal snRNP assembly (GO:0000387) | 3.32166162 |
| 72 | pseudouridine synthesis (GO:0001522) | 3.31926050 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.31577703 |
| 74 | ribosome biogenesis (GO:0042254) | 3.31203167 |
| 75 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.28645897 |
| 76 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.28645897 |
| 77 | protein localization to mitochondrion (GO:0070585) | 3.27801062 |
| 78 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.27679896 |
| 79 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.27679896 |
| 80 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.27679896 |
| 81 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.26967544 |
| 82 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.26967544 |
| 83 | rRNA metabolic process (GO:0016072) | 3.26384771 |
| 84 | cullin deneddylation (GO:0010388) | 3.24247756 |
| 85 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.22760018 |
| 86 | chromatin remodeling at centromere (GO:0031055) | 3.22508436 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.20455349 |
| 88 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.20455349 |
| 89 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.19952823 |
| 90 | 7-methylguanosine mRNA capping (GO:0006370) | 3.19904723 |
| 91 | macromolecular complex disassembly (GO:0032984) | 3.19654964 |
| 92 | protein deneddylation (GO:0000338) | 3.19260994 |
| 93 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.18513360 |
| 94 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.15565210 |
| 95 | hydrogen ion transmembrane transport (GO:1902600) | 3.14592348 |
| 96 | 7-methylguanosine RNA capping (GO:0009452) | 3.14488345 |
| 97 | RNA capping (GO:0036260) | 3.14488345 |
| 98 | ATP synthesis coupled proton transport (GO:0015986) | 3.12903323 |
| 99 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.12903323 |
| 100 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.10809836 |
| 101 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.10429232 |
| 102 | deoxyribonucleotide catabolic process (GO:0009264) | 3.09438299 |
| 103 | UTP biosynthetic process (GO:0006228) | 3.06544291 |
| 104 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.05426493 |
| 105 | regulation of mitochondrial translation (GO:0070129) | 3.04420604 |
| 106 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.04174613 |
| 107 | amino acid salvage (GO:0043102) | 3.03949632 |
| 108 | L-methionine salvage (GO:0071267) | 3.03949632 |
| 109 | L-methionine biosynthetic process (GO:0071265) | 3.03949632 |
| 110 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.01886712 |
| 111 | positive regulation of ligase activity (GO:0051351) | 3.01453810 |
| 112 | telomere maintenance via telomere lengthening (GO:0010833) | 3.00814028 |
| 113 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.99951082 |
| 114 | protein targeting to membrane (GO:0006612) | 2.99442669 |
| 115 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.99102265 |
| 116 | deoxyribose phosphate catabolic process (GO:0046386) | 2.98934660 |
| 117 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.98189417 |
| 118 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.98189417 |
| 119 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.96494943 |
| 120 | mitochondrial transport (GO:0006839) | 2.93640037 |
| 121 | protein maturation by protein folding (GO:0022417) | 2.91723043 |
| 122 | oxidative phosphorylation (GO:0006119) | 2.91524241 |
| 123 | mRNA catabolic process (GO:0006402) | 2.89603502 |
| 124 | response to interferon-beta (GO:0035456) | 2.89444529 |
| 125 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.89419437 |
| 126 | spliceosomal complex assembly (GO:0000245) | 2.89133619 |
| 127 | mitotic metaphase plate congression (GO:0007080) | 2.87426734 |
| 128 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.86512698 |
| 129 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.86391987 |
| 130 | purine nucleotide salvage (GO:0032261) | 2.85681010 |
| 131 | cellular response to interferon-beta (GO:0035458) | 2.84546587 |
| 132 | ribosome assembly (GO:0042255) | 2.84405097 |
| 133 | protein targeting (GO:0006605) | 2.83984457 |
| 134 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.81449623 |
| 135 | cell cycle G1/S phase transition (GO:0044843) | 2.81449623 |
| 136 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.79184336 |
| 137 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.78204547 |
| 138 | termination of RNA polymerase I transcription (GO:0006363) | 2.78038850 |
| 139 | RNA catabolic process (GO:0006401) | 2.76347753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74973768 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.19943343 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.06017818 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.76393740 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.64779363 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.62401061 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.50961988 |
| 8 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.24204724 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.21300218 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.10676178 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.92293066 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.91636180 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79816634 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.71281504 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69420992 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.68048318 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.67539580 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.53822823 |
| 19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.53395490 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47350142 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.42899587 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.37795723 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.37002769 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.34184116 |
| 25 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24381018 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24089413 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.23789579 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17577114 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.15937448 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10822432 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.10769585 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07670688 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.02909474 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.98810832 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.90427198 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.86022297 |
| 37 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.83220735 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.81213797 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.80405910 |
| 40 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79254263 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74855459 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69319472 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.67930039 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67903062 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67745597 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60488221 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54865027 |
| 48 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54563781 |
| 49 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.52131082 |
| 50 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52066454 |
| 51 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49541477 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.48583788 |
| 53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46182612 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.43842773 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43651891 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40124503 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39596958 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38342149 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37965015 |
| 60 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35910172 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35891576 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34734888 |
| 63 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27837825 |
| 64 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27593505 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21507937 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19868769 |
| 67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17748135 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17524246 |
| 69 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15132001 |
| 70 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14624939 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13078311 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13035357 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11905891 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10114146 |
| 75 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08229232 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07985451 |
| 77 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07444310 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07237266 |
| 79 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06842057 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06775878 |
| 81 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06669096 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05907280 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04242796 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04213784 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01091213 |
| 86 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00973682 |
| 87 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00604199 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00442394 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99044282 |
| 90 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97966400 |
| 91 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97240205 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96220784 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95207485 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94615218 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93104809 |
| 96 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92356444 |
| 97 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92027969 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90063086 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89545880 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 0.89545170 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89275275 |
| 102 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.89090945 |
| 103 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.88334483 |
| 104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88019091 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87640382 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 0.86181881 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85417944 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85096189 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82740868 |
| 110 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.82409243 |
| 111 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82265939 |
| 112 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.81067459 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79895436 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77427556 |
| 115 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.73349279 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72917471 |
| 117 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.72900383 |
| 118 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.72252332 |
| 119 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.72227560 |
| 120 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.70598838 |
| 121 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.70245342 |
| 122 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.68775924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.82005474 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.59318619 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.30235307 |
| 4 | MP0008057_abnormal_DNA_replication | 3.18523591 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.11922734 |
| 6 | MP0003077_abnormal_cell_cycle | 2.95350159 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.94444963 |
| 8 | MP0003186_abnormal_redox_activity | 2.83329863 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.71756679 |
| 10 | MP0008058_abnormal_DNA_repair | 2.68649213 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.32204157 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.28743044 |
| 13 | MP0003718_maternal_effect | 2.13777397 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.05501507 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 1.97234041 |
| 16 | MP0003786_premature_aging | 1.89309538 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 1.87565236 |
| 18 | MP0002163_abnormal_gland_morphology | 1.84246435 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.77930890 |
| 20 | MP0008995_early_reproductive_senescence | 1.77209333 |
| 21 | MP0002396_abnormal_hematopoietic_system | 1.75865359 |
| 22 | MP0001873_stomach_inflammation | 1.74318037 |
| 23 | MP0009785_altered_susceptibility_to | 1.68814750 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.65724492 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.60453502 |
| 26 | MP0005671_abnormal_response_to | 1.52309216 |
| 27 | MP0001853_heart_inflammation | 1.52205898 |
| 28 | MP0002132_abnormal_respiratory_system | 1.49663437 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.49553579 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.44246829 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.44070219 |
| 32 | MP0009764_decreased_sensitivity_to | 1.42300059 |
| 33 | MP0003436_decreased_susceptibility_to | 1.39570686 |
| 34 | MP0000490_abnormal_crypts_of | 1.39212770 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.38442468 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.36604290 |
| 37 | MP0001730_embryonic_growth_arrest | 1.36407608 |
| 38 | MP0005025_abnormal_response_to | 1.34020193 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.33924320 |
| 40 | MP0001764_abnormal_homeostasis | 1.33263415 |
| 41 | MP0000343_altered_response_to | 1.30697258 |
| 42 | MP0000350_abnormal_cell_proliferation | 1.26412623 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.23856772 |
| 44 | MP0005451_abnormal_body_composition | 1.23690658 |
| 45 | MP0001905_abnormal_dopamine_level | 1.23131766 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.21328675 |
| 47 | MP0003724_increased_susceptibility_to | 1.20852013 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.20095796 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.19754590 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.19427779 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.19427779 |
| 52 | MP0000313_abnormal_cell_death | 1.18903755 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.18327802 |
| 54 | MP0002398_abnormal_bone_marrow | 1.16393724 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.13716181 |
| 56 | MP0004142_abnormal_muscle_tone | 1.11970554 |
| 57 | MP0001529_abnormal_vocalization | 1.11272785 |
| 58 | MP0003195_calcinosis | 1.10640712 |
| 59 | MP0004147_increased_porphyrin_level | 1.10362087 |
| 60 | MP0002722_abnormal_immune_system | 1.10200678 |
| 61 | MP0002723_abnormal_immune_serum | 1.10099546 |
| 62 | MP0002095_abnormal_skin_pigmentation | 1.09934775 |
| 63 | MP0000685_abnormal_immune_system | 1.09784259 |
| 64 | MP0001800_abnormal_humoral_immune | 1.08260743 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.08137363 |
| 66 | MP0002452_abnormal_antigen_presenting | 1.06859292 |
| 67 | MP0002429_abnormal_blood_cell | 1.06303799 |
| 68 | MP0006054_spinal_hemorrhage | 1.05546322 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.04512053 |
| 70 | MP0009840_abnormal_foam_cell | 1.04437183 |
| 71 | MP0009697_abnormal_copulation | 1.04010582 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.03954823 |
| 73 | MP0001819_abnormal_immune_cell | 1.03767201 |
| 74 | MP0002419_abnormal_innate_immunity | 1.02488557 |
| 75 | MP0008469_abnormal_protein_level | 1.02448547 |
| 76 | MP0000716_abnormal_immune_system | 1.02397241 |
| 77 | MP0003123_paternal_imprinting | 1.02291728 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 1.00829059 |
| 79 | MP0005389_reproductive_system_phenotype | 1.00150836 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.99435859 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98192237 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 0.97541035 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.97276452 |
| 84 | MP0005410_abnormal_fertilization | 0.93740221 |
| 85 | MP0006082_CNS_inflammation | 0.92333816 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.91205076 |
| 87 | MP0005083_abnormal_biliary_tract | 0.90903584 |
| 88 | MP0000858_altered_metastatic_potential | 0.90879683 |
| 89 | MP0005408_hypopigmentation | 0.90532348 |
| 90 | MP0002405_respiratory_system_inflammati | 0.89818143 |
| 91 | MP0001919_abnormal_reproductive_system | 0.89567200 |
| 92 | MP0000358_abnormal_cell_content/ | 0.89184248 |
| 93 | MP0002080_prenatal_lethality | 0.88352561 |
| 94 | MP0005365_abnormal_bile_salt | 0.87586440 |
| 95 | MP0001697_abnormal_embryo_size | 0.87272866 |
| 96 | MP0003011_delayed_dark_adaptation | 0.87037468 |
| 97 | MP0008872_abnormal_physiological_respon | 0.86360175 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.83845844 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.83719421 |
| 100 | MP0003303_peritoneal_inflammation | 0.82985199 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.82455005 |
| 102 | MP0005332_abnormal_amino_acid | 0.82175379 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.82015712 |
| 104 | MP0005387_immune_system_phenotype | 0.81797820 |
| 105 | MP0001790_abnormal_immune_system | 0.81797820 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 0.81641798 |
| 107 | MP0003866_abnormal_defecation | 0.81242287 |
| 108 | MP0005085_abnormal_gallbladder_physiolo | 0.80117954 |
| 109 | MP0003646_muscle_fatigue | 0.79209516 |
| 110 | MP0005380_embryogenesis_phenotype | 0.78898676 |
| 111 | MP0001672_abnormal_embryogenesis/_devel | 0.78898676 |
| 112 | MP0005266_abnormal_metabolism | 0.78733500 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.78584630 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.78425183 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.78348882 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.77423448 |
| 117 | MP0003136_yellow_coat_color | 0.77239896 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.77186463 |
| 119 | MP0005636_abnormal_mineral_homeostasis | 0.77004452 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.75971429 |
| 121 | MP0002160_abnormal_reproductive_system | 0.75442695 |
| 122 | MP0001542_abnormal_bone_strength | 0.75343094 |
| 123 | MP0002210_abnormal_sex_determination | 0.74626040 |
| 124 | MP0003984_embryonic_growth_retardation | 0.74244001 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.74106966 |
| 126 | MP0002938_white_spotting | 0.73502355 |
| 127 | MP0005360_urolithiasis | 0.72786913 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.72388485 |
| 129 | MP0003315_abnormal_perineum_morphology | 0.71160922 |
| 130 | MP0008877_abnormal_DNA_methylation | 0.67733357 |
| 131 | MP0002933_joint_inflammation | 0.67687050 |
| 132 | MP0000598_abnormal_liver_morphology | 0.67523349 |
| 133 | MP0002006_tumorigenesis | 0.67517913 |
| 134 | MP0009763_increased_sensitivity_to | 0.66556259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.18279347 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.08348371 |
| 3 | Reticulocytopenia (HP:0001896) | 4.76264525 |
| 4 | Macrocytic anemia (HP:0001972) | 3.90008344 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.79116326 |
| 6 | Hepatic necrosis (HP:0002605) | 3.71652780 |
| 7 | Mitochondrial inheritance (HP:0001427) | 3.69379293 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.57273916 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.56385769 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 3.54483527 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.49796816 |
| 12 | Increased CSF lactate (HP:0002490) | 3.42327158 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.37578773 |
| 14 | Pallor (HP:0000980) | 3.34190599 |
| 15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.34018591 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.33357213 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.33357213 |
| 18 | Breast hypoplasia (HP:0003187) | 3.25255661 |
| 19 | Increased serum lactate (HP:0002151) | 3.25215571 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.25108361 |
| 21 | Acute encephalopathy (HP:0006846) | 3.24489927 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.18402448 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.18402448 |
| 24 | Aplastic anemia (HP:0001915) | 3.17300830 |
| 25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.07616680 |
| 26 | Progressive macrocephaly (HP:0004481) | 3.02634442 |
| 27 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.01377516 |
| 28 | Exertional dyspnea (HP:0002875) | 2.98502152 |
| 29 | Rough bone trabeculation (HP:0100670) | 2.96138935 |
| 30 | Oral leukoplakia (HP:0002745) | 2.92263254 |
| 31 | Optic disc pallor (HP:0000543) | 2.80687022 |
| 32 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.79802971 |
| 33 | Multiple enchondromatosis (HP:0005701) | 2.79355168 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.74278571 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.69553086 |
| 36 | Stomatitis (HP:0010280) | 2.69315776 |
| 37 | Microretrognathia (HP:0000308) | 2.65649143 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.64427593 |
| 39 | Cerebral edema (HP:0002181) | 2.64039080 |
| 40 | Lactic acidosis (HP:0003128) | 2.63355374 |
| 41 | Abnormality of renal resorption (HP:0011038) | 2.57687575 |
| 42 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54611268 |
| 43 | Exercise intolerance (HP:0003546) | 2.47358510 |
| 44 | Respiratory failure (HP:0002878) | 2.46237891 |
| 45 | Nausea (HP:0002018) | 2.43935915 |
| 46 | Emotional lability (HP:0000712) | 2.42443864 |
| 47 | Abnormal trabecular bone morphology (HP:0100671) | 2.41553049 |
| 48 | Carpal bone hypoplasia (HP:0001498) | 2.40925386 |
| 49 | Microvesicular hepatic steatosis (HP:0001414) | 2.40685162 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.33790009 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.33326490 |
| 52 | Poor head control (HP:0002421) | 2.29835509 |
| 53 | Chromsome breakage (HP:0040012) | 2.27716785 |
| 54 | Reduced antithrombin III activity (HP:0001976) | 2.27023828 |
| 55 | Abnormal hemoglobin (HP:0011902) | 2.26027737 |
| 56 | Absent thumb (HP:0009777) | 2.24714766 |
| 57 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23521017 |
| 58 | Pancytopenia (HP:0001876) | 2.21665561 |
| 59 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18875730 |
| 60 | Megaloblastic anemia (HP:0001889) | 2.10585286 |
| 61 | CNS demyelination (HP:0007305) | 2.10484807 |
| 62 | Secondary amenorrhea (HP:0000869) | 2.10479718 |
| 63 | Progressive muscle weakness (HP:0003323) | 2.10220825 |
| 64 | Sparse eyelashes (HP:0000653) | 2.10105168 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09882519 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.09882519 |
| 67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.09856784 |
| 68 | Respiratory difficulties (HP:0002880) | 2.08585294 |
| 69 | Abnormality of the preputium (HP:0100587) | 2.08046999 |
| 70 | Hyperphosphaturia (HP:0003109) | 2.06976763 |
| 71 | Lethargy (HP:0001254) | 2.04332988 |
| 72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.04238343 |
| 73 | Muscle fiber atrophy (HP:0100295) | 2.03583736 |
| 74 | X-linked dominant inheritance (HP:0001423) | 2.02387114 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.02129369 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.02129369 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02129369 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02129369 |
| 79 | Increased IgM level (HP:0003496) | 2.01262300 |
| 80 | Abnormality of T cell physiology (HP:0011840) | 2.01091359 |
| 81 | Trismus (HP:0000211) | 2.00770705 |
| 82 | Thrombocytosis (HP:0001894) | 2.00667610 |
| 83 | Type 2 muscle fiber atrophy (HP:0003554) | 2.00174212 |
| 84 | IgM deficiency (HP:0002850) | 1.98639662 |
| 85 | Irregular epiphyses (HP:0010582) | 1.97735836 |
| 86 | Glycosuria (HP:0003076) | 1.97122870 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 1.97122870 |
| 88 | Premature graying of hair (HP:0002216) | 1.95797639 |
| 89 | Bone marrow hypocellularity (HP:0005528) | 1.95737747 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 1.95102467 |
| 91 | Parakeratosis (HP:0001036) | 1.94825223 |
| 92 | IgG deficiency (HP:0004315) | 1.93451489 |
| 93 | Abnormality of reticulocytes (HP:0004312) | 1.90161914 |
| 94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87291000 |
| 95 | Abnormality of serum amino acid levels (HP:0003112) | 1.86501536 |
| 96 | Patellar aplasia (HP:0006443) | 1.86294769 |
| 97 | Meckel diverticulum (HP:0002245) | 1.86256412 |
| 98 | Petechiae (HP:0000967) | 1.85391161 |
| 99 | Leukodystrophy (HP:0002415) | 1.84156936 |
| 100 | Colon cancer (HP:0003003) | 1.82751349 |
| 101 | Duplicated collecting system (HP:0000081) | 1.81838043 |
| 102 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81364698 |
| 103 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.80919687 |
| 104 | 11 pairs of ribs (HP:0000878) | 1.80527745 |
| 105 | B lymphocytopenia (HP:0010976) | 1.79933542 |
| 106 | Cleft eyelid (HP:0000625) | 1.78263300 |
| 107 | Abnormality of the renal collecting system (HP:0004742) | 1.78159900 |
| 108 | Congenital, generalized hypertrichosis (HP:0004540) | 1.77937242 |
| 109 | Abnormality of the ileum (HP:0001549) | 1.76550213 |
| 110 | Degeneration of anterior horn cells (HP:0002398) | 1.75966228 |
| 111 | Abnormality of the anterior horn cell (HP:0006802) | 1.75966228 |
| 112 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.74702658 |
| 113 | Neutropenia (HP:0001875) | 1.74044591 |
| 114 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73237885 |
| 115 | Methylmalonic aciduria (HP:0012120) | 1.72439852 |
| 116 | Triphalangeal thumb (HP:0001199) | 1.71860825 |
| 117 | Cerebral palsy (HP:0100021) | 1.69689009 |
| 118 | Blindness (HP:0000618) | 1.69107441 |
| 119 | Panhypogammaglobulinemia (HP:0003139) | 1.68815446 |
| 120 | Abnormal pupillary function (HP:0007686) | 1.68515379 |
| 121 | Progressive microcephaly (HP:0000253) | 1.68430119 |
| 122 | Abnormality of B cell number (HP:0010975) | 1.68207552 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.66360122 |
| 124 | Gliosis (HP:0002171) | 1.66256073 |
| 125 | Pancreatic cysts (HP:0001737) | 1.65871606 |
| 126 | Testicular atrophy (HP:0000029) | 1.64030862 |
| 127 | Pancreatic fibrosis (HP:0100732) | 1.63780115 |
| 128 | Acute hepatic failure (HP:0006554) | 1.62633737 |
| 129 | Vomiting (HP:0002013) | 1.62335227 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 1.61726325 |
| 131 | Abnormality of T cells (HP:0002843) | 1.61581828 |
| 132 | Obstructive lung disease (HP:0006536) | 1.57070515 |
| 133 | Chronic obstructive pulmonary disease (HP:0006510) | 1.57070515 |
| 134 | Increased serum ferritin (HP:0003281) | 1.56309957 |
| 135 | Premature ovarian failure (HP:0008209) | 1.54319364 |
| 136 | Abnormal urine phosphate concentration (HP:0012599) | 1.51180377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.26391066 |
| 2 | BUB1 | 4.61050765 |
| 3 | NME2 | 4.00829600 |
| 4 | STK16 | 3.91653780 |
| 5 | EIF2AK1 | 3.74643128 |
| 6 | WEE1 | 3.22029291 |
| 7 | TLK1 | 2.61954908 |
| 8 | PBK | 2.56852082 |
| 9 | EIF2AK3 | 2.42166403 |
| 10 | SRPK1 | 2.33110855 |
| 11 | VRK1 | 2.26779286 |
| 12 | PIM2 | 2.23046888 |
| 13 | TESK2 | 2.20495645 |
| 14 | IRAK3 | 2.12156402 |
| 15 | IRAK4 | 1.86771587 |
| 16 | NUAK1 | 1.85607059 |
| 17 | MAP3K12 | 1.77015689 |
| 18 | ACVR1B | 1.74544737 |
| 19 | PLK4 | 1.73479018 |
| 20 | MST4 | 1.70232941 |
| 21 | CDC7 | 1.65534819 |
| 22 | BCKDK | 1.55278169 |
| 23 | BRSK2 | 1.54999667 |
| 24 | RPS6KA4 | 1.49159026 |
| 25 | MAP4K2 | 1.45877340 |
| 26 | TAOK3 | 1.44324895 |
| 27 | NME1 | 1.42453677 |
| 28 | ZAK | 1.38508885 |
| 29 | PDK2 | 1.38265769 |
| 30 | DYRK3 | 1.37637014 |
| 31 | BLK | 1.36465112 |
| 32 | MKNK1 | 1.33984251 |
| 33 | PLK1 | 1.33357294 |
| 34 | ADRBK2 | 1.32103813 |
| 35 | TTK | 1.27836947 |
| 36 | RIPK4 | 1.26506310 |
| 37 | KDR | 1.25715042 |
| 38 | AURKB | 1.23278225 |
| 39 | MAP4K1 | 1.20073895 |
| 40 | TSSK6 | 1.14941698 |
| 41 | GRK6 | 1.13908999 |
| 42 | STK4 | 1.07723937 |
| 43 | AURKA | 1.04481438 |
| 44 | MAP3K11 | 1.03837952 |
| 45 | CDK7 | 1.01618205 |
| 46 | NEK2 | 1.01496036 |
| 47 | DAPK1 | 0.98631711 |
| 48 | NEK9 | 0.98250952 |
| 49 | EIF2AK2 | 0.97681086 |
| 50 | ILK | 0.96026258 |
| 51 | TEC | 0.94316874 |
| 52 | RPS6KB2 | 0.94206093 |
| 53 | MKNK2 | 0.93681403 |
| 54 | ABL2 | 0.93224047 |
| 55 | BMPR2 | 0.91841916 |
| 56 | INSRR | 0.89239107 |
| 57 | ATR | 0.88887638 |
| 58 | PLK3 | 0.87789091 |
| 59 | DAPK3 | 0.87599506 |
| 60 | FLT3 | 0.87500460 |
| 61 | GRK1 | 0.86656997 |
| 62 | LIMK1 | 0.84796445 |
| 63 | PASK | 0.84286941 |
| 64 | IKBKB | 0.83701266 |
| 65 | PIM1 | 0.83228838 |
| 66 | CSNK1G3 | 0.82493695 |
| 67 | TESK1 | 0.82078293 |
| 68 | TNK2 | 0.79929879 |
| 69 | CDK8 | 0.78725551 |
| 70 | ITK | 0.78396990 |
| 71 | MAP3K8 | 0.76944004 |
| 72 | MUSK | 0.76325093 |
| 73 | IRAK1 | 0.76236652 |
| 74 | CSNK2A1 | 0.76005259 |
| 75 | RPS6KA5 | 0.75587797 |
| 76 | BRAF | 0.75312643 |
| 77 | LRRK2 | 0.74671990 |
| 78 | BRSK1 | 0.72546845 |
| 79 | DYRK2 | 0.69649299 |
| 80 | TBK1 | 0.69266473 |
| 81 | BTK | 0.68810369 |
| 82 | STK10 | 0.68643806 |
| 83 | FES | 0.68383418 |
| 84 | TGFBR1 | 0.67133705 |
| 85 | TXK | 0.66950515 |
| 86 | CSNK2A2 | 0.65860093 |
| 87 | CHEK2 | 0.65257858 |
| 88 | MAP3K3 | 0.64787707 |
| 89 | EPHA2 | 0.63349634 |
| 90 | TYK2 | 0.62704704 |
| 91 | NLK | 0.62061368 |
| 92 | NEK1 | 0.61486943 |
| 93 | PRKCQ | 0.60879377 |
| 94 | CSNK1G1 | 0.60452700 |
| 95 | GRK7 | 0.59957947 |
| 96 | SCYL2 | 0.59782302 |
| 97 | CCNB1 | 0.58747588 |
| 98 | CDK4 | 0.57971310 |
| 99 | MAPKAPK3 | 0.56960908 |
| 100 | ZAP70 | 0.56902893 |
| 101 | LYN | 0.56162393 |
| 102 | KIT | 0.54850639 |
| 103 | MAP2K3 | 0.54677667 |
| 104 | ARAF | 0.53408988 |
| 105 | OBSCN | 0.52986046 |
| 106 | TRIM28 | 0.52120510 |
| 107 | MAP3K14 | 0.51194097 |
| 108 | MARK3 | 0.50152882 |
| 109 | CDK19 | 0.48060184 |
| 110 | CHEK1 | 0.47283416 |
| 111 | IKBKE | 0.46465731 |
| 112 | PAK1 | 0.45047324 |
| 113 | CLK1 | 0.43939111 |
| 114 | TAF1 | 0.43073611 |
| 115 | TAOK2 | 0.42981675 |
| 116 | PIK3CG | 0.42251868 |
| 117 | MAPKAPK5 | 0.42017314 |
| 118 | STK24 | 0.41429664 |
| 119 | YES1 | 0.40289475 |
| 120 | PINK1 | 0.39464342 |
| 121 | MAP2K6 | 0.38410166 |
| 122 | MYLK | 0.38047988 |
| 123 | CSNK1G2 | 0.37915243 |
| 124 | MAPK11 | 0.36825945 |
| 125 | CSNK1A1L | 0.36820250 |
| 126 | SYK | 0.36536135 |
| 127 | JAK3 | 0.35853097 |
| 128 | ADRBK1 | 0.35819730 |
| 129 | IRAK2 | 0.34717017 |
| 130 | MELK | 0.34418296 |
| 131 | CDK2 | 0.30388588 |
| 132 | PRKCI | 0.29617365 |
| 133 | LCK | 0.29572105 |
| 134 | CDK3 | 0.29528270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.58688014 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.96026575 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.69652056 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.48689726 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.02828219 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.75062790 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.59877554 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.58923565 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.42429122 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.38407257 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.35980866 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.18720316 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.12778072 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.99853069 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96349469 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 1.91684601 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90475007 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76786774 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.61625733 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55503320 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48880116 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48544307 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38184691 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.34971602 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.34186844 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33237213 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33172133 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32487901 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.30707368 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.28620088 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26855499 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21059907 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14443899 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08159408 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07968023 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07296435 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06852107 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01585642 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00001496 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94725125 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91911577 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90772079 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90413077 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89370879 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87250259 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86580911 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85914483 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84982564 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84349758 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83118433 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81097280 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80540722 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77366274 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76859027 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75185987 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74415718 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.74078720 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73592406 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72152626 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72148075 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70452563 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69699788 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.69315106 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69110918 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67596352 |
| 66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59353796 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58708360 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58298679 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56905044 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56306606 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56163660 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53423653 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.52648352 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50099934 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49221771 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48864619 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48835359 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48486034 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47831171 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47233530 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46081093 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45858479 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43114946 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42474411 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41985642 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39434176 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.39422177 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38911533 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38261975 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37795567 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37745738 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37492349 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36109664 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.36011438 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35882884 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35837587 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34745944 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33977802 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33927475 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32981302 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32344511 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31179465 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30742191 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29954931 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29774422 |
| 106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.29482577 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29316300 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.28062795 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27344942 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26609234 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26424840 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25642104 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25225358 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.25101165 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24825733 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.23835853 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.21154131 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20176063 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.19463772 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.17620316 |

